Literature DB >> 12676867

Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection.

Susanne Häußler1, Isabell Ziegler1, Alexandra Löttel1, Franz V Götz1, Manfred Rohde1, Dirk Wehmhöhner1, Selvan Saravanamuthu1, Burkhard Tümmler1, Ivo Steinmetz1.   

Abstract

Pseudomonas aeruginosa, an opportunistic human pathogen and ubiquitous environmental bacterium, is capable of forming specialized bacterial communities, referred to as biofilm. The results of this study demonstrate that the unique environment of the cystic fibrosis (CF) lung seems to select for a subgroup of autoaggregative and hyperpiliated P. aeruginosa small-colony variants (SCVs). These morphotypes showed increased fitness under stationary growth conditions in comparison with clonal wild-types and fast-growing revertants isolated from the SCV population in vitro. In accordance with the SCVs being hyperpiliated, they exhibited increased twitching motility and capacity for biofilm formation. In addition, the SCVs attached strongly to the pneumocytic cell line A549. The emergence of these highly adherent SCVs within the CF lung might play a key role in the pathogenesis of P. aeruginosa lung infection, where a biofilm mode of growth is thought to be responsible for persistent infection.

Entities:  

Mesh:

Year:  2003        PMID: 12676867     DOI: 10.1099/jmm.0.05069-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  89 in total

1.  Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life.

Authors:  Matthew R Parsek; Clay Fuqua
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

2.  Evidence for polyadenylated mRNA in Pseudomonas aeruginosa.

Authors:  Senthil Selvan Saravanamuthu; Franz von Götz; Prabhakar Salunkhe; Rathinam Chozhavendan; Robert Geffers; Jan Buer; Burkhard Tümmler; Ivo Steinmetz
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

3.  Self-generated diversity produces "insurance effects" in biofilm communities.

Authors:  Blaise R Boles; Matthew Thoendel; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

4.  Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis.

Authors:  Michael Schneider; Kathrin Mühlemann; Sara Droz; Sabine Couzinet; Carmen Casaulta; Stefan Zimmerli
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

5.  Endogenous oxidative stress produces diversity and adaptability in biofilm communities.

Authors:  Blaise R Boles; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

6.  Elevated levels of the second messenger c-di-GMP contribute to antimicrobial resistance of Pseudomonas aeruginosa.

Authors:  Kajal Gupta; Julie Liao; Olga E Petrova; K E Cherny; Karin Sauer
Journal:  Mol Microbiol       Date:  2014-04-09       Impact factor: 3.501

7.  Comparative physiological study of the wild type and the small colony variant of Pseudomonas aeruginosa 20265 under controlled growth conditions.

Authors:  W Sabra; A M Haddad; A-P Zeng
Journal:  World J Microbiol Biotechnol       Date:  2013-10-16       Impact factor: 3.312

Review 8.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

9.  Inter- and intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome.

Authors:  Dirk Wehmhöner; Susanne Häussler; Burkhard Tümmler; Lothar Jänsch; Florian Bredenbruch; Jürgen Wehland; Ivo Steinmetz
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

10.  Role of mutation in Pseudomonas aeruginosa biofilm development.

Authors:  Tim C R Conibear; Samuel L Collins; Jeremy S Webb
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.